#retatrutide

[ follow ]
#peptides #appetite-suppression #glp-1-gip-glucagon #glp-1gipglucagon-triple-agonist #weight-loss-drugs
Alternative medicine
fromNatural Health News
4 weeks ago

A "Hack" For Making Ultraprocessed Foods Less Unhealthy, Eating "Wild Foods," What Sports Make You Smarter (And Increase Longevity) & More: Solosode #493

Microdosing Retatrutide (≈0.25 mg/week) suppresses appetite via GLP-1, GIP, and glucagon pathways and is obtained through physician-screened peptide providers.
Medicine
fromBusiness Insider
1 month ago

Eli Lilly is close to launching the strongest weight-loss drug ever. Somehow, gym bros are already taking it to shred fat.

Retatrutide, a triple-agonist drug by Eli Lilly, promises dramatic weight loss and muscle preservation but remains in clinical trials until at least 2026–2027.
[ Load more ]